Individualized immunoglobulin therapy in chronic immune‐mediated peripheral neuropathies*

Despite the well‐recognized importance of immunoglobulin therapy individualization during the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP), the pathway to best achieve optimization is unknown. There are many pharmacokinetic and immunobiologic variables that can potentially i...

Descripción completa

Detalles Bibliográficos
Autores principales: Allen, Jeffrey A., Berger, Melvin, Querol, Luis, Kuitwaard, Krista, Hadden, Robert D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033159/
https://www.ncbi.nlm.nih.gov/pubmed/29573033
http://dx.doi.org/10.1111/jns.12262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033159/
https://www.ncbi.nlm.nih.gov/pubmed/29573033
http://dx.doi.org/10.1111/jns.12262

Ejemplares similares